NanoVation Therapeutics develops innovative lipid nanoparticle (lcLNP™) technology for the delivery of genetic medicines, targeting extrahepatic tissues like immune cells and tumors. Catering to pharmaceutical and biotech organizations, we provide a comprehensive platform that enhances mRNA, DNA, and gene editing programs to tackle previously untreatable diseases.
No jobs found. Subscribe below to get notified when we find something for you.
Searching